Naohide Tanaka Selected Research

Naohide Tanaka Research Topics

Disease

14	Hepatocellular Carcinoma (Hepatoma) 03/2016 - 04/2002
13	Chronic Hepatitis C 01/2013 - 01/2003
9	Liver Diseases (Liver Disease) 08/2013 - 04/2002
9	Chronic Hepatitis (Chronic Active Hepatitis) 11/2009 - 08/2002
9	Liver Cirrhosis (Hepatic Cirrhosis) 11/2009 - 01/2003
7	Neoplasms (Cancer) 03/2016 - 12/2002
6	Hepatitis C 01/2009 - 01/2003
3	Hepatitis B 01/2008 - 01/2003
3	Fibrosis (Cirrhosis) 01/2005 - 08/2002
2	Infections 01/2008 - 01/2005
2	Cholangitis 04/2007 - 01/2004
2	Hepatitis 12/2002 - 08/2002
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 06/2018
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018
1	Neoplasm Metastasis (Metastasis) 10/2008
1	Stomach Neoplasms (Stomach Cancer) 10/2008
1	IgA Vasculitis (Purpura, Schoenlein Henoch) 01/2008
1	Body Weight (Weight, Body) 09/2007
1	Hypersensitivity (Allergy) 04/2007
1	Inflammation (Inflammations) 02/2005
1	Hypercholesterolemia 02/2005
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2004
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2004
1	Autoimmune Diseases (Autoimmune Disease) 01/2004
1	Autoimmune Hepatitis 01/2004
1	Hashimoto Disease (Thyroiditis, Hashimoto) 01/2004
1	Chronic Hepatitis B 01/2003
1	Liver Failure 01/2003
1	Polyarteritis Nodosa (Periarteritis Nodosa) 12/2002
1	Carcinogenesis 12/2002

Drug/Important Bio-Agent (IBA)

10	InterferonsIBA 08/2013 - 01/2003
6	RNA (Ribonucleic Acid)IBA 01/2008 - 04/2002
5	DNA (Deoxyribonucleic Acid)IBA 01/2008 - 08/2002
3	ZincIBA 11/2012 - 11/2006
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2008 - 01/2003
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2005 - 08/2002
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 09/2009 - 01/2006
2	Interferon-alpha (Interferon Alfa)IBA 01/2009 - 01/2005
2	EnzymesIBA 01/2008 - 01/2003
2	ImmunosorbentsIBA 01/2008 - 01/2003
2	Ribavirin (Virazole)FDA LinkGeneric 09/2007 - 06/2006
2	Antiviral Agents (Antivirals)IBA 01/2005 - 12/2002
2	AntigensIBA 01/2005 - 09/2004
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 06/2018
1	Pharmaceutical PreparationsIBA 03/2016
1	Therapeutic UsesIBA 03/2016
1	GelatinIBA 03/2016
1	miriplatinIBA 03/2016
1	Alanine (L-Alanine)FDA Link 11/2012
1	Serum AlbuminIBA 11/2012
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2012
1	polaprezinc (Z 103)IBA 11/2009
1	CarcinogensIBA 09/2009
1	Fluorouracil (Carac)FDA LinkGeneric 10/2008
1	Cisplatin (Platino)FDA LinkGeneric 10/2008
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2008
1	Etoposide (VP 16)FDA LinkGeneric 10/2008
1	Leucovorin (Folinic Acid)FDA Link 10/2008
1	Dust (House Dust)FDA Link 04/2007
1	CholesterolIBA 02/2005
1	Alanine Transaminase (SGPT)IBA 02/2005
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2005
1	C-Reactive ProteinIBA 02/2005
1	Malondialdehyde (Propanedial)IBA 02/2005
1	oxidized low density lipoproteinIBA 02/2005
1	LDL Lipoproteins (beta Lipoproteins)IBA 02/2005
1	AntioxidantsIBA 02/2005
1	anticentromere antibodyIBA 01/2004
1	SteroidsIBA 01/2004
1	Inosine Triphosphate (ITP)IBA 01/2004
1	Amino Acids FDA Link 10/2003
1	Proteins (Proteins, Gene)FDA Link 10/2003
1	AmmoniaIBA 10/2003
1	Branched-Chain Amino AcidsIBA 10/2003
1	Carbon Tetrachloride (Tetrachloromethane)IBA 10/2003
1	4-dimethylamino-3',4'-dimethoxychalconeIBA 01/2003
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2002
1	Indicators and Reagents (Reagents)IBA 08/2002
1	AntibodiesIBA 04/2002

Therapy/Procedure

10	Therapeutics 08/2013 - 01/2003
1	Percutaneous Coronary Intervention 01/2018
1	Catheters 03/2016
1	Combination Drug Therapy (Combination Chemotherapy) 10/2008
1	Endoscopes 01/2008
1	Blood Component Removal (Apheresis) 01/2005
1	Intraperitoneal Injections 10/2003